Preexisting Autoantibodies and Immune Related Adverse Events in Metastatic Urothelial Carcinoma Patients Treated by Pembrolizumab.
暂无分享,去创建一个
M. Peyromaure | F. Goldwasser | C. Goulvestre | F. Batteux | J. Alexandre | O. Huillard | M. Bretagne | J. Arrondeau | Zahra Castel-Ajgal | S. Zaibet